CN112451185A - A kind of high-strength biologically active intervertebral cage and its manufacturing method - Google Patents

A kind of high-strength biologically active intervertebral cage and its manufacturing method Download PDF

Info

Publication number
CN112451185A
CN112451185A CN202011599971.4A CN202011599971A CN112451185A CN 112451185 A CN112451185 A CN 112451185A CN 202011599971 A CN202011599971 A CN 202011599971A CN 112451185 A CN112451185 A CN 112451185A
Authority
CN
China
Prior art keywords
layer
inner layer
strength
intervertebral cage
middle layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202011599971.4A
Other languages
Chinese (zh)
Other versions
CN112451185B (en
Inventor
邵惠锋
景卓荦
贺永
年志恒
龚友平
刘海强
陈慧鹏
李文欣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hangzhou Dianzi University
Original Assignee
Hangzhou Dianzi University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hangzhou Dianzi University filed Critical Hangzhou Dianzi University
Priority to CN202011599971.4A priority Critical patent/CN112451185B/en
Publication of CN112451185A publication Critical patent/CN112451185A/en
Application granted granted Critical
Publication of CN112451185B publication Critical patent/CN112451185B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2/4455Joints for the spine, e.g. vertebrae, spinal discs for the fusion of spinal bodies, e.g. intervertebral fusion of adjacent spinal bodies, e.g. fusion cages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30771Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • A61F2/30942Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/025Other specific inorganic materials not covered by A61L27/04 - A61L27/12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/04Metals or alloys
    • A61L27/06Titanium or titanium alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30329Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30771Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
    • A61F2002/30772Apertures or holes, e.g. of circular cross section
    • A61F2002/30784Plurality of holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • A61F2002/3097Designing or manufacturing processes using laser
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • A61F2002/30985Designing or manufacturing processes using three dimensional printing [3DP]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602Type of release, e.g. controlled, sustained, slow
    • A61L2300/604Biodegradation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/38Materials or treatment for tissue regeneration for reconstruction of the spine, vertebrae or intervertebral discs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Manufacturing & Machinery (AREA)
  • Geometry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Prostheses (AREA)

Abstract

本发明公开了一种高强度生物活性椎间融合器及其制造方法,所述椎间融合器由外层,中间层和内层三个部分组成,所述中间层被包裹在所述外层内部,所述内层安装在所述中间层内;所述外层为软材料;所述中间层为多孔结构,内部孔道完全贯通;所述内层为两种或者多种多孔结构的生物活性材料的组合,内部孔道完全贯通,可以是钙镁硅酸盐,硅酸盐,或者磷酸盐等的组合,也可以是生物活性材料附带有一些的特殊功能。所述的中间层包括进入口和轨道,所述内层通过所述进入口进入中间层内部,所述内层活动安装在所述轨道上。本发明的高强度生物活性椎间融合器具有高的力学强度,良好的位置稳定性,良好的生物活性,同时还可以添加多种功能。

Figure 202011599971

The invention discloses a high-strength biologically active intervertebral cage and a manufacturing method thereof. The intervertebral cage is composed of three parts: an outer layer, a middle layer and an inner layer, and the middle layer is wrapped in the outer layer Inside, the inner layer is installed in the middle layer; the outer layer is a soft material; the middle layer is a porous structure, and the inner pores are completely penetrated; the inner layer is the biological activity of two or more porous structures The combination of materials, the internal pores are completely penetrated, it can be a combination of calcium magnesium silicate, silicate, or phosphate, etc., or it can be a biologically active material with some special functions. The middle layer includes an inlet port and a track, the inner layer enters the middle layer through the inlet port, and the inner layer is movably installed on the track. The high-strength biologically active intervertebral cage of the present invention has high mechanical strength, good positional stability, good biological activity, and can also add various functions.

Figure 202011599971

Description

High-strength bioactive intervertebral fusion cage and manufacturing method thereof
Technical Field
The invention relates to an instrument in the technical field of medical instruments and a manufacturing method thereof, in particular to a high-strength bioactive intervertebral fusion cage and a manufacturing method thereof.
Background
With the aging of the population, degenerative diseases of the spine, which mainly cause neck and shoulder pain and pain in the waist and lower extremities, are seriously affecting the work and life of people. Vertebral body fusion between vertebral bodies is one of the main methods for treating degenerative diseases of the spine at present. Through the diligent efforts of researchers, various kinds of interbody cages have been developed in succession and are gradually applied to the clinic. An ideal cage needs to correct spinal deformity, restore normal physiologic curvature, maintain intervertebral space stability, and most importantly promote bone fusion. However, many disadvantages of the current fusion cage include poor biocompatibility of the fusion cage material, collapse of the intervertebral space, late inflammatory response, etc.
With the development of the disciplines of mechanics, materials science, tissue engineering and the like, researchers are studying new intervertebral fusion cages through multidisciplinary intersection, but no matter how the materials of the fusion cages change, the following requirements must be met: the fusion cage has no toxic or side effect in a human body and has better biocompatibility; has suitable biomechanical characteristics; to ensure stability of the intervertebral space and promote bone fusion; after being implanted into a human body, the implant should have a larger fusion area with the upper and lower vertebral bodies and should be closer to the normal physiological curvature of the human body in structure.
Disclosure of Invention
The present invention addresses the above-described deficiencies of the prior art by providing a high strength bioactive interbody fusion cage and a method of making the same.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows: a high strength bioactive interbody cage, said interbody cage is made up of three parts of the outer layer, intermediate layer and inner layer, said intermediate layer is wrapped up in the inside of said outer layer, said inner layer is installed in said intermediate layer;
the outer layer is made of soft materials, can be hydrogel, can also be silica gel and the like;
the middle layer is of a porous structure, and the inner pore passage is completely communicated and can be titanium alloy or PEEK and the like;
the inner layer is a combination of two or more bioactive materials with porous structures, the inner pore channels are completely penetrated, the bioactive materials can be a combination of calcium magnesium silicate, phosphate and the like, and the bioactive materials have some special functions, such as tumor growth inhibition, bone promotion and vascularization promotion.
Preferably, the middle layer of the high-strength bioactive intervertebral fusion device comprises an inlet and a track, the inner layer enters the middle layer through the inlet, the inner layer is movably mounted on the track, the whole structure of the middle layer can be hollowed according to the requirements of application occasions, the topology structure of the whole structure is optimized, the fusion device is lighter on the premise of meeting the use requirements, and the middle layer is used for bearing external loads.
Preferably, the porosity of the middle layer is 30-60%, the pore diameter is 50-500 microns, and the pore form structure can be square, rectangular, parallelogram, spherical and the like;
preferably, the entry opening and the track in the intermediate layer constitute one unit, and the number of the units may be 1, 2, or more. In practical application, the number of the units is determined according to the structure of the middle layer and the required number of the inner layers, and the positions of the units in the middle layer are determined according to the structure of the middle layer.
Preferably, the porosity of the inner layer of the high-strength bioactive intervertebral fusion device is 30-90%, the pore diameter is 200-1000 microns, the thickness is 0.3-5 mm, the pore form structure can be a grid square, a rectangle, a parallelogram and the like, and the inner layer structure can be a plurality of bioactive materials.
Preferably, the external shape of the inner layer of the high-strength bioactive intervertebral fusion device is the same as that of the inlet of the middle layer, and can be triangular, circular and the like, the external shape of the inner layer is matched with the cross-sectional shape of the track, the size of the inner layer is slightly smaller than that of the inlet, and the inner layer can enter the inner part of the middle layer through the inlet. Through the design of entry port special construction, the inlayer can only reach inside the intermediate level through the entry port under a position state, and after the inlayer entered into the intermediate level inside, the inlayer can follow the intraformational track cooperation of intermediate level, guarantees that the inlayer is a relatively stable position state inside the intermediate level, for example when the shape of inlayer is triangle-shaped, orbital cross sectional shape is the V type, when the shape of inlayer is circular, orbital cross sectional shape is the semicircle type, when a plurality of inlayers entered into on the track, the inlayer can carry out horizontal migration on the track to hardly come out from the entry port, guarantee that the inlayer is inside the intermediate level always.
In practical application, the outer layer is wrapped outside the middle layer, so that the hard material can be prevented from directly contacting with surrounding hard bones to cause abrasion. The mechanical strength of the intermediate layer can be adjusted by adjusting the porosity, the pore diameter and the pore form structure of the intermediate layer. The degradation speed and the ion release speed of the biological material can be controlled by adjusting the porosity, the pore diameter, the pore form structure and the porosity of the middle layer. By adjusting the number of inner layers or the number of materials of the same structure in one unit, the release amount of ions can be controlled, so that the fusion device has better functions. By adjusting the material of the inner layer, the fusion device can have different functions or integrate multiple functions, such as tumor inhibition, vascularization promotion, bone regeneration promotion and the like.
Preferably, the present invention relates to a method for manufacturing the high-strength bioactive intervertebral fusion cage, comprising the steps of:
1) respectively selecting the material types of the middle layer, the outer layer and the inner layer according to application occasions;
2) designing the structure of the intermediate layer according to the application occasions and the material characteristics of the intermediate layer, and then manufacturing the intermediate layer by using equipment;
3) designing the structure of the outer layer according to the structure of the middle layer and the material characteristics of the outer layer, and then manufacturing the outer layer;
4) designing the structure of the inner layer according to the application occasion and the material characteristics of the inner layer, mixing the inner layer material with a solvent to respectively obtain uniformly dispersed biological ink, and then manufacturing a plurality of inner layer blanks by using 3D printing equipment;
5) respectively placing the inner layer blanks into a high-temperature furnace for high-temperature calcination, and cooling to obtain a plurality of inner layer structures;
6) placing a plurality of inner-layer structures on a track sequentially through the inlet openings of the middle layers;
7) and (3) wrapping the intermediate layer structure containing the inner layer by using the outer layer to obtain the high-strength bioactive intervertebral fusion device.
Preferably, the calcination temperature is 950%oC-1150oC, the temperature rising speed is 1 to 3 oCMin, and the heat preservation time is 1-6 hours.
Compared with the prior art, the invention has the following advantages:
firstly, the surface structure of the high-strength bioactive intervertebral fusion device manufactured by the invention is soft and is not easy to abrade with the contact part.
Secondly, the high-strength bioactive intervertebral fusion device manufactured by the invention has good bioactivity in vivo and can promote bone regeneration and repair.
Thirdly, the invention can manufacture the high-strength bioactive intervertebral fusion cage with multiple functions, and meets the complex and changeable practical application requirements.
Fourthly, the method for manufacturing the high-strength bioactive intervertebral fusion cage is convenient to operate and low in manufacturing cost.
Drawings
FIG. 1 is a schematic flow chart of a method of manufacturing a high strength bioactive intervertebral cage according to the present disclosure;
FIG. 2 is a schematic view of a high strength bioactive intervertebral cage of the present invention;
fig. 3 is a partial schematic view of a high strength bioactive intervertebral cage of the present invention.
Detailed Description
The following examples are given for the detailed implementation and specific operation of the present invention, but the scope of the present invention is not limited to the following examples.
As shown in figure 2, the high-strength bioactive intervertebral fusion device comprises an outer layer, a middle layer and an inner layer, wherein the middle layer is wrapped inside the outer layer, and the inner layer is arranged inside the middle layer;
the outer layer is made of soft material, which can be hydrogel or silica gel;
the middle layer is of a porous structure, and the inner pore passage is completely penetrated, and can be titanium alloy, PEEK (polyether ether ketone) and the like;
the inner layer is a combination of two or more bioactive materials with porous structures, the inner pore channels are completely penetrated, the bioactive materials can be a combination of calcium magnesium silicate, phosphate and the like, and the bioactive materials have some special functions, such as tumor growth inhibition, bone promotion and vascularization promotion.
The intermediate level of above-mentioned high strength biological activity interbody fusion cage includes inlet port and track, and above-mentioned inlayer passes through inside above-mentioned inlet port gets into the intermediate level, and above-mentioned inlayer movable mounting is on above-mentioned track, and above-mentioned intermediate level is according to the needs of application scenario, and whole structure can carry out the fretwork and handle, optimizes through carrying out topological structure to whole structure, can make the fusion cage lighter under the prerequisite that satisfies the operation requirement, and the effect in intermediate level is used for bearing external load.
The porosity of the middle layer is 30-60%, the pore diameter is 50-500 microns, and the pore form structure can be square, rectangular, parallelogram, spherical and the like;
the inlet and the track in the intermediate layer form a unit, and the number of the units can be 1, 2 or more. In practical application, the number of the units is determined according to the structure of the middle layer and the required number of the inner layers, and the positions of the units in the middle layer are determined according to the structure of the middle layer.
The porosity of the inner layer of the high-strength bioactive interbody fusion cage is 30-90%, the pore diameter is 200-1000 microns, the thickness is 0.3-5 mm, the pore form structure can be a grid square, a rectangle, a parallelogram and the like, and the inner layer structure can be a plurality of various bioactive materials.
The external shape of the inner layer of the high-strength bioactive intervertebral fusion device is the same as that of the inlet of the middle layer and can be triangular, circular and the like, the external shape of the inner layer is matched with the cross section shape of the track, the size of the inner layer is slightly smaller than that of the inlet, and the inner layer can enter the inner part of the middle layer through the inlet. Through the design of inlet port structure, above-mentioned inlayer can only reach inside the intermediate level through the inlet port under a position state, when the inlayer enters into the inside back in intermediate level, the inlayer can follow the intraformational track cooperation in above-mentioned intermediate level, guarantee that the inlayer is a relatively stable position state in the intermediate level inside, for example when the shape of inlayer is triangle-shaped, orbital cross sectional shape is the V type, when the shape of inlayer is circular, orbital cross sectional shape is the semicircle type, when a plurality of inlayers enter into on the track, the inlayer can carry out horizontal migration on the track, and hardly come out from the inlet port, guarantee that the inlayer is inside the intermediate level all the time.
In practical application, the outer layer is wrapped outside the middle layer, so that the hard material can be prevented from directly contacting with surrounding hard bones to cause abrasion. The mechanical strength of the intermediate layer can be adjusted by adjusting the porosity, the pore diameter and the pore form structure of the intermediate layer. The degradation speed and the ion release speed of the biological material can be controlled by adjusting the porosity, the pore diameter, the pore form structure and the porosity of the middle layer. By adjusting the number of inner layers or the number of materials of the same structure in one unit, the release amount of ions can be controlled, so that the fusion device has better functions. By adjusting the material of the inner layer, the fusion device can have different functions or integrate multiple functions, such as tumor inhibition, vascularization promotion, bone regeneration promotion and the like.
As shown in fig. 1, it is a flow chart of the manufacturing method of the high strength bioactive intervertebral fusion device of the present invention, comprising the following steps:
1) respectively selecting the material types of the middle layer, the outer layer and the inner layer according to application occasions;
2) designing the structure of the intermediate layer according to the application occasions and the material characteristics of the intermediate layer, and then manufacturing the intermediate layer by using equipment;
3) designing the structure of the outer layer according to the structure of the middle layer and the material characteristics of the outer layer, and then manufacturing the outer layer;
4) designing the structure of the inner layer according to the application occasion and the material characteristics of the inner layer, mixing the inner layer material with a solvent to respectively obtain uniformly dispersed biological ink, and then manufacturing a plurality of inner layer blanks by using 3D printing equipment;
5) respectively placing the inner layer blanks into a high-temperature furnace for high-temperature calcination, and cooling to obtain a plurality of inner layer structures;
6) placing a plurality of inner-layer structures on a track sequentially through the inlet openings of the middle layers;
7) and (3) wrapping the intermediate layer structure containing the inner layer by using the outer layer to obtain the high-strength bioactive intervertebral fusion device.
The above calcination temperatureDegree of 950oC-1150oC, the temperature rising speed is 1 to 3 oCMin, and the heat preservation time is 1-6 hours.
Example 1
The manufacturing method of the intervertebral fusion device with the functions of resisting tumor, promoting osteogenesis and promoting vascularization for the lumbar intervertebral fusion comprises the following steps:
1) selecting titanium alloy as a material of the middle layer, silica gel as a material of the outer layer, calcium magnesium silicate with the magnesium content of 1.6 percent as an inner layer material A, calcium silicate material containing strontium as an inner layer material B, calcium silicate material containing copper as an inner layer material C, and calcium silicate material with anti-tumor drugs as an inner layer material D;
2) designing the outline of a titanium alloy intermediate layer according to the mechanical properties required by the interbody fusion cage and the material properties of the titanium alloy, wherein the internal porosity is 30%, the pore diameter is 100 microns, the pore-shaped structure is in a grid shape, 2 units are arranged in the intermediate layer and are respectively arranged on the uppermost surface and the lowermost surface of the intermediate layer, the shape of an inlet is triangular, the cross section of a track is in a V shape, then guiding the designed intermediate layer structure model into metal 3D printing equipment, and stacking layer by layer through a selective laser melting process to obtain the titanium alloy intermediate layer structure;
3) according to the upper and lower surface structures of the middle layer and the material characteristics of the silica gel, the structure of the outer layer is designed to be the same as the upper and lower surface structures of the middle layer, the size of the structure is slightly smaller than that of the upper and lower surface structures of the middle layer, the silica gel can be firmly wrapped outside the middle layer, and then the structure of the outer layer of the silica gel is manufactured by a pouring method;
4) 4 structures of the inner layer are respectively designed according to the anti-tumor property, the bone regeneration property, the vascularization promoting property and the repair property required by the application occasion and the properties of four materials, the porosity of the inner layer A is 60 percent, the pore diameter is 500 micrometers, the pore form structure is a grid square, the porosity of the inner layer B is 50 percent, the pore diameter is 400 micrometers, the pore form structure is a grid square, the porosity of the inner layer C is 50 percent, the pore diameter is 400 micrometers, the pore form structure is a grid square, the porosity of the inner layer D is 60 percent, the pore diameter is 700 micrometers, the pore form structure is a grid square, the four inner layers are triangles with the same follow-in inlet, but the size of the triangles is 0.5mm smaller than the enter-in inlet, the shape and the size of the inner layers are just matched with the cross-section shape and the size of the rail, the four inner layer materials are respectively mixed with the solvent to obtain the uniformly dispersed biological inks A and, c and D, guiding the structural model of the inner layer into 3D printing equipment, and then respectively obtaining inner layer blanks A, B, C and D by utilizing the 3D printing equipment in a layer-by-layer overlapping mode;
5) putting the inner layer blank A into a high-temperature furnace, and passing through 1150oCalcining at high temperature for 4 hr, cooling to obtain inner layer A, putting inner layer blank B in high-temperature furnace, and passing through 1100 deg.CoCalcining the C at high temperature for 4 hours, cooling to obtain an inner layer B, putting the inner layer blank C into a high-temperature furnace, and passing through 1100 DEG CoCalcining the C at high temperature for 4 hours, cooling to obtain an inner layer C, putting the inner layer blank D into a high-temperature furnace, and passing through 1100 DEG CoCalcining the C at high temperature for 4 hours, cooling to obtain an inner layer D, soaking the inner layer D in a solution containing the anti-tumor drug for several times, and drying to obtain the inner layer D carrying the anti-tumor drug;
6) placing 1 inner layer D on a track through an inlet on the upper surface of the middle layer, inclining the middle layer to enable the inner layer D to move to the other end of the track along the track, then flatly placing the middle layer, enabling the inner layer A to be placed on the track through the inlet, inclining the middle layer again, enabling the inner layer A to move to the other end of the track and be in contact with the inner layer D, continuing to operate in such a way, sequentially placing the inner layers C, B, B, C, A and D until the 8 inner layer structures are positioned on the track on the upper surface of the middle layer according to the sequence of DACBBCAD, then overturning the middle layer, adding the inner layer structures into the inlet on the lower surface of the middle layer, filling the track on the lower surface with the 8 inner layer structures as the operation process of adding the inner layer structures into the upper surface, and finally obtaining the middle layer loaded with the;
7) respectively wrapping the upper surface and the outer surface of the intermediate layer obtained in the step 6) by using the silica gel obtained in the step 3) to obtain the high-strength bioactive intervertebral fusion device, wherein the structural schematic diagram of the key part is shown in fig. 3.

Claims (5)

1.一种高强度生物活性椎间融合器,其特征在于,所述椎间融合器由外层,中间层和内层三个部分组成,所述中间层被包裹在所述外层内部,所述内层安装在所述中间层内;1. a high-strength biologically active intervertebral cage is characterized in that, described intervertebral cage is made up of three parts of outer layer, middle layer and inner layer, and described middle layer is wrapped inside described outer layer, the inner layer is mounted within the intermediate layer; 所述外层为软材料,为水凝胶或硅胶;The outer layer is a soft material, such as hydrogel or silica gel; 所述中间层为多孔结构,内部孔道完全贯通,为钛合金或PEEK等;The intermediate layer is a porous structure, and the internal pores are completely penetrated, which is titanium alloy or PEEK, etc.; 所述内层为两种或者多种多孔结构的生物活性材料的组合,内部孔道完全贯通,为钙镁硅酸盐,硅酸盐,或者磷酸盐的组合,或者为生物活性材料附带有一些功能,包括抑制肿瘤生长,促血管化和促成骨;The inner layer is a combination of two or more bioactive materials with porous structures, and the internal pores are completely penetrated, which is a combination of calcium magnesium silicate, silicate, or phosphate, or the bioactive material has some functions. , including tumor growth inhibition, vascularization and osteogenesis; 所述的高强度生物活性椎间融合器的中间层包括进入口和轨道,所述内层通过所述进入口进入中间层内部,所述内层活动安装在所述轨道上;The middle layer of the high-strength biologically active intervertebral cage includes an access port and a track, the inner layer enters the interior of the middle layer through the access port, and the inner layer is movably installed on the track; 所述中间层的孔隙率为30~60%,孔径为50~500微米,孔形态结构为正方形,长方形,平行四边形或球形;The porosity of the intermediate layer is 30-60%, the pore diameter is 50-500 microns, and the pore morphological structure is square, rectangular, parallelogram or spherical; 所述中间层内的进入口和轨道组成一个单元,所述单元至少一个以上。The inlet and the track in the intermediate layer form a unit, and the unit is at least one or more. 2.根据权利要求1所述的高强度生物活性椎间融合器,其特征在于,所述的高强度生物活性椎间融合器的内层的孔隙率为30~90%,孔径为200~1000微米,厚度为0.3~5mm,孔形态结构为网格正方形,长方形,平行四边形。2. The high-strength biologically active intervertebral cage according to claim 1, wherein the inner layer of the high-strength biologically active intervertebral cage has a porosity of 30-90%, and a pore diameter of 200-1000 Micron, the thickness is 0.3~5mm, and the pore shape structure is grid square, rectangle, parallelogram. 3.根据权利要求1所述的高强度生物活性椎间融合器,其特征在于,所述的高强度生物活性椎间融合器的内层的外部形状跟所述中间层的进入口的形状相同;所述内层的外部形状跟所述轨道的截面形状相配合,所述内层的尺寸比所述进入口的尺寸略小,内层能够通过进入口进入到所述中间层的内部。3. The high-strength bioactive intervertebral cage according to claim 1, wherein the outer shape of the inner layer of the high-strength bioactive intervertebral cage is the same as the shape of the inlet port of the middle layer ; The outer shape of the inner layer matches the cross-sectional shape of the track, the size of the inner layer is slightly smaller than the size of the inlet port, and the inner layer can enter the interior of the intermediate layer through the inlet port. 4.一种根据权利要求1所述的高强度生物活性椎间融合器的制造方法,其特征在于,包括以下步骤:4. a kind of manufacture method of high-strength bioactive intervertebral cage according to claim 1, is characterized in that, comprises the following steps: 1)根据应用场合分别选择中间层,外层和内层的材料类型;1) Select the material types of the middle layer, outer layer and inner layer according to the application; 2)根据应用场合和中间层的材料特性设计中间层的结构,然后利用设备制造中间层;2) Design the structure of the intermediate layer according to the application and the material properties of the intermediate layer, and then use the equipment to manufacture the intermediate layer; 3)根据中间层的结构和外层的材料特性,设计外层的结构,然后制造外层;3) According to the structure of the middle layer and the material properties of the outer layer, design the structure of the outer layer, and then manufacture the outer layer; 4)根据应用场合和内层的材料特性设计内层的结构,将内层材料跟溶剂混合分别得到分散均匀的生物墨水,然后利用3D打印设备制造多个内层毛坯;4) Design the structure of the inner layer according to the application and the material properties of the inner layer, mix the inner layer material with the solvent to obtain a uniformly dispersed bio-ink, and then use 3D printing equipment to manufacture multiple inner layer blanks; 5)将内层毛坯分别放到高温炉中高温煅烧,冷却后得到多个内层结构;5) Put the inner layer blanks into a high temperature furnace for high temperature calcination, and obtain multiple inner layer structures after cooling; 6)将多个内层结构按照顺序依次经过中间层的进入口放置到轨道上;6) Place multiple inner layer structures on the track through the entrance of the middle layer in sequence; 7)用外层将含有内层的中间层结构包裹住,得到高强度生物活性椎间融合器。7) Wrap the middle layer structure including the inner layer with the outer layer to obtain a high-strength bioactive intervertebral cage. 5.根据权利要求4所述的高强度生物活性椎间融合器的制造方法,其特征在于,所述的煅烧温度为950oC-1150oC,升温速度为1-3 oC/min,保温时间1-6小时。5. the manufacture method of high-strength biologically active intervertebral cage according to claim 4, is characterized in that, described calcination temperature is 950 o C-1150 o C, and the heating rate is 1-3 o C/min, The holding time is 1-6 hours.
CN202011599971.4A 2020-12-30 2020-12-30 A high-strength bioactive intervertebral fusion device and a manufacturing method thereof Active CN112451185B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011599971.4A CN112451185B (en) 2020-12-30 2020-12-30 A high-strength bioactive intervertebral fusion device and a manufacturing method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011599971.4A CN112451185B (en) 2020-12-30 2020-12-30 A high-strength bioactive intervertebral fusion device and a manufacturing method thereof

Publications (2)

Publication Number Publication Date
CN112451185A true CN112451185A (en) 2021-03-09
CN112451185B CN112451185B (en) 2024-10-08

Family

ID=74802101

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011599971.4A Active CN112451185B (en) 2020-12-30 2020-12-30 A high-strength bioactive intervertebral fusion device and a manufacturing method thereof

Country Status (1)

Country Link
CN (1) CN112451185B (en)

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09173436A (en) * 1995-12-25 1997-07-08 Kyocera Corp Bioprosthesis member and manufacturing method thereof
US20050177237A1 (en) * 2001-04-12 2005-08-11 Ben Shappley Spinal cage insert, filler piece and method of manufacturing
US20050246021A1 (en) * 2004-04-29 2005-11-03 Ringeisen Timothy A Compressed porous materials suitable for implant
CN105769382A (en) * 2016-02-24 2016-07-20 浙江大学 Biological active porous structure support suitable for bone regeneration and repair and manufacturing method thereof
CN107753159A (en) * 2017-11-10 2018-03-06 湖北联结生物材料有限公司 The reinforced homogeneous allogenic bone cervical vertebral fusion cage of the compound new bone formation of multi-disc
CN108451673A (en) * 2017-02-20 2018-08-28 中国科学院沈阳自动化研究所 A kind of Invasive lumbar fusion device material-structure
CN109223257A (en) * 2018-11-09 2019-01-18 唐接福 A kind of (3D printing) artificial vertebral body system
CN110063820A (en) * 2019-06-03 2019-07-30 华中科技大学同济医学院附属协和医院 With active 3D printing Invasive lumbar fusion device of interface Bone Ingrowth and preparation method thereof
CN111921009A (en) * 2020-08-13 2020-11-13 中山大学附属第一医院 Implant material suitable for bone defect and spinal fusion transplantation, implant and preparation method thereof
CN112603602A (en) * 2020-12-30 2021-04-06 杭州电子科技大学 Bioactive intervertebral fusion device and manufacturing method thereof

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09173436A (en) * 1995-12-25 1997-07-08 Kyocera Corp Bioprosthesis member and manufacturing method thereof
US20050177237A1 (en) * 2001-04-12 2005-08-11 Ben Shappley Spinal cage insert, filler piece and method of manufacturing
US20050246021A1 (en) * 2004-04-29 2005-11-03 Ringeisen Timothy A Compressed porous materials suitable for implant
CN105769382A (en) * 2016-02-24 2016-07-20 浙江大学 Biological active porous structure support suitable for bone regeneration and repair and manufacturing method thereof
CN108451673A (en) * 2017-02-20 2018-08-28 中国科学院沈阳自动化研究所 A kind of Invasive lumbar fusion device material-structure
CN107753159A (en) * 2017-11-10 2018-03-06 湖北联结生物材料有限公司 The reinforced homogeneous allogenic bone cervical vertebral fusion cage of the compound new bone formation of multi-disc
CN109223257A (en) * 2018-11-09 2019-01-18 唐接福 A kind of (3D printing) artificial vertebral body system
CN110063820A (en) * 2019-06-03 2019-07-30 华中科技大学同济医学院附属协和医院 With active 3D printing Invasive lumbar fusion device of interface Bone Ingrowth and preparation method thereof
CN111921009A (en) * 2020-08-13 2020-11-13 中山大学附属第一医院 Implant material suitable for bone defect and spinal fusion transplantation, implant and preparation method thereof
CN112603602A (en) * 2020-12-30 2021-04-06 杭州电子科技大学 Bioactive intervertebral fusion device and manufacturing method thereof

Also Published As

Publication number Publication date
CN112451185B (en) 2024-10-08

Similar Documents

Publication Publication Date Title
Pei et al. 3D printed titanium scaffolds with homogeneous diamond-like structures mimicking that of the osteocyte microenvironment and its bone regeneration study
Zhao et al. Bionic design and 3D printing of porous titanium alloy scaffolds for bone tissue repair
CN105877874B (en) Porous bone ware of Bionic Design class bone and preparation method thereof
Gao et al. Additive manufacturing technique-designed metallic porous implants for clinical application in orthopedics
CN1209170C (en) Porous synthetic bone graft and method of manufacture thereof
US8287915B2 (en) Bone restorative carrier mediums
Cesarano III et al. Customization of load‐bearing hydroxyapatite lattice scaffolds
US20020120336A1 (en) Porous intervertebral spacer
CN112966411A (en) High-performance medical implant based on body representative unit stress and preparation method and application thereof
CN102440852A (en) A hybrid porous structure intervertebral fusion device and its preparation method
CN106270517A (en) A kind of network structure part preparation method with composition gradient transitional lay double with hole
CN109620475A (en) One kind being implanted into preparation based on CT data individuation porous titanium alloy shin bone
CN111544644B (en) Calcium phosphate scaffold with multi-scale pore structure, preparation method and application
CN112603602A (en) Bioactive intervertebral fusion device and manufacturing method thereof
CN115024866B (en) A low elastic modulus and high strength biomedical variable gradient porous scaffold structure and construction method thereof
CN115090903A (en) Medical implant based on molecular sieve functional elements and preparation method thereof
Misra et al. Process-structure-biofunctional paradigm in cellular structured implants: an overview and perspective on the synergy between additive manufacturing, bio-mechanical behaviour and biological functions
CN112451185A (en) A kind of high-strength biologically active intervertebral cage and its manufacturing method
CN105921746B (en) One kind is based on elastically-deformable titanium enhancing block and its construction method
CN115154676A (en) Biological fixation type pedicle screw and preparation method and application thereof
CN111957974B (en) Preparation method of graded porous titanium tantalum rod
EP3478331B1 (en) Biomaterial
RU2689794C1 (en) Porous structure for medical implants
CN112451752B (en) High-strength degradable intramedullary nail and manufacturing method thereof
CN119501100B (en) Shape memory alloy bone scaffold imitating Haversian system, 4D printing preparation method and application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant